Skip to main content
NANOCO GROUP PLC logo

NANOCO GROUP PLC — Investor Relations & Filings

Ticker · NANO ISIN · GB00B01JLR99 LEI · 213800HOSJEZO1KOCV33 IL Manufacturing
Open in API
Filings indexed 962 across all filing types
Latest filing 2022-09-12 Management Reports
Country GB United Kingdom
Listing IL NANO

About NANOCO GROUP PLC

https://www.nanocotechnologies.com/

Nanoco Group PLC is a nanotechnology company specializing in the research, development, manufacturing, and licensing of heavy-metal-free nanomaterials. The company is a world leader in patented cadmium-free quantum dots (CFQDs®), which are semiconductor nanoparticles whose optical and electronic properties can be precisely tuned for specific customer requirements. This technology platform enables a wide range of commercial applications. Key markets include advanced displays for consumer electronics and sensing applications in the Near-Infrared (NIR) and Short-Wave Infrared (SWIR) spectrums for sectors such as mobile devices, automotive, healthcare, and security.

Recent filings

Filing Released Lang Actions
Trading Update & Directorate Change
Management Reports Classification · 99% confidence The document is clearly identified as an RNS (Regulatory News Service) announcement, indicated by the 'RNS Number' header and the concluding boilerplate text referencing RNS, the London Stock Exchange, and the Financial Conduct Authority. The content itself announces two key items: an improving 'Trading Update - FY23 outlook' (which suggests an Earnings Release or Interim Report update, but this document is the announcement, not the full report) and a 'Directorate Change' (a change in Non-Executive Director). Since it contains both a trading update summary and a management change, it is a broad regulatory announcement. Given the presence of the RNS identifier and the nature of the content (a mix of operational update and board change), the most appropriate general classification for a UK regulatory news service release that doesn't fit a more specific category like 10-K, ER, or MANG exclusively is RNS, as it is the mechanism of release. However, since it explicitly details a Directorate Change, MANG is a strong candidate. Since it also provides a trading outlook update, it overlaps with ER. Because it is formatted as a standard RNS release and contains multiple types of corporate news, RNS serves as the best fit for the delivery mechanism/format, or we must choose the most prominent non-financial news item. The Directorate Change is a specific, discrete event announced here. Let's re-evaluate the definitions. MANG is for 'Announcement of changes in the company's board of directors or senior management.' This document explicitly announces a Directorate Change. While it also contains a trading update, the management change is a distinct, reportable event. Given the dual nature, RNS is the catch-all, but MANG is highly specific to one component. Since the document is a formal regulatory announcement (RNS) covering multiple topics, RNS is often the correct classification for these mixed-content regulatory wires. However, if we must prioritize the specific corporate action, MANG is relevant. Let's check if it fits ER (Earnings Release - initial announcement of periodical financial results, key highlights only). The trading update provides key highlights. Given the structure and the explicit mention of a Directorate Change, and the fact that RNS is the fallback, I will prioritize the specific corporate action announced: the Directorate Change (MANG), as it is a definitive event, while the trading update is an outlook adjustment. If the document were purely the trading update, ER would fit. Since it's a mixed regulatory filing, RNS is safe, but MANG captures the specific personnel event. I will classify it as RNS as it is the primary delivery format for this type of mixed announcement on the LSE.
2022-09-12 English
Litigation Update – Revised Trial Date
Legal Proceedings Report Classification · 99% confidence The document begins with an RNS Number (6639Y) and is dated 07 September 2022, indicating it is a regulatory announcement disseminated via the London Stock Exchange's RNS service. The content explicitly discusses a 'Litigation Update' regarding the rescheduling of a trial between Nanoco and Samsung. This subject matter—updates on significant lawsuits or legal matters—directly aligns with the definition for Legal Proceedings Report (LTR). Although it is distributed via RNS, the specific content is about litigation, making LTR the most precise classification over the general fallback RNS.
2022-09-07 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is clearly identified as an 'RNS Number' filing from 'Nanoco Group PLC' dated 01 September 2022. The content details a 'DIRECTOR/PDMR SHAREHOLDING' transaction, specifically reporting the 'SALE OF ORDINARY SHARES' by a 'Person Closely Associated (PCA) with a PDMR' (Henry Turcan, Non-Executive Director). This type of insider transaction reporting, mandated by regulations like the EU Market Abuse Regulation, directly corresponds to the definition of Director's Dealing. Therefore, the appropriate classification is DIRS.
2022-09-01 English
Two Grant Funding Awards
Environmental & Social Information Classification · 99% confidence The document begins with 'RNS Number : 6695X' and is dated '31 August 2022'. It announces that Nanoco Group PLC has secured grant funding from Innovate UK for two projects. The text concludes with standard disclaimers related to RNS distribution and mentions that the information is considered inside information upon publication via a Regulatory Information Service (RIS). This structure—a brief announcement of a specific, non-financial event (grant awards) released through the RNS system—is characteristic of a general regulatory announcement that doesn't fit the specific categories like ER, 10-K, or DIV. Since it is a formal, immediate announcement disseminated via the London Stock Exchange's news service (RNS), and it doesn't fit the criteria for RPA (it is the news itself, not just an announcement *about* a report), the most appropriate general category is Regulatory Filings (RNS).
2022-08-31 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled with "RNS Number : 6383X" and contains the standard header/footer information associated with RNS (Regulatory News Service) announcements from the London Stock Exchange. The content is a "TR-1: Standard form for notification of major holdings," which details changes in significant share ownership (crossing a threshold from 23.88% to 22.95%). This type of filing directly corresponds to the definition of a Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2022-08-30 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is an official notification filed with the RNS (Regulatory News Service) of the London Stock Exchange. The content explicitly details 'DIRECTOR/PDMR SHAREHOLDING' transactions, specifically reporting the 'SALE OF ORDINARY SHARES' by a Person Closely Associated (PCA) with a Non-Executive Director. This perfectly matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The structure, including the RNS Number and the 'Notification of Dealing Form', confirms this is a regulatory filing concerning insider transactions.
2022-08-30 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.